Weight Loss Medications
22 articles on Weight Loss Medications, written by Shotlee and medically reviewed for clinical accuracy.
Semaglutide for Older Adults: Weight Loss & Heart Health Gains
A comprehensive analysis of the STEP trials reveals that once-weekly semaglutide significantly benefits older adults with obesity, leading to substantial weight loss and improvements in key cardiometabolic markers. This article delves into the findings, implications, and considerations for this important demographic.
7 min read
DIY Weight Loss Injections: The Dangerous Rise of 'Skinny Jabs'
As the cost of popular weight loss medications like Mounjaro and Wegovy climbs, a growing number of individuals are resorting to dangerous, unapproved DIY 'skinny jabs' sourced illegally online. This article delves into the risks, motivations, and the alarming reality of this trend.
7 min read
GLP-1 Pills for Weight Loss: 8 Key Insights Before You Begin
GLP-1 medications are now available as pills for weight loss, offering a needle-free alternative. This comprehensive guide explores what you need to know before starting, including efficacy, absorption, side effects, and lifestyle considerations.
12 min read
GLP-1 Weight Loss Drugs: The Risk of Stopping and Restarting
New research suggests that the effectiveness of popular GLP-1 weight loss medications may significantly diminish with intermittent use. Understand the implications for your health journey.
7 min read
GLP-1 Drugs and 'Ozempic Breath': A Sweet Twist for Hershey
The rise of GLP-1 medications like Ozempic and Wegovy is transforming health and lifestyles, but it's also leading to an unexpected side effect: 'Ozempic breath'. This phenomenon is creating a surprising boon for confectionary companies, particularly Hershey, as consumers seek relief. Learn more about this fascinating intersection of pharmaceuticals and consumer goods.
7 min read
Beyond the Scale: Navigating Weight Loss and Appearance Concerns
Significant weight loss, often achieved with medications like GLP-1 agonists, can bring about transformative health benefits but also raises questions about changes in appearance. This article delves into the phenomenon of 'Mounjaro face,' discusses how to approach sensitive conversations about appearance with friends and family, and offers practical advice for maintaining well-being during and after weight loss.
9 min read
Elon Musk Before and After: Tesla CEO's Look After Mounjaro
Elon Musk's dramatic before and after photos have gone viral, spotlighting his slimmer appearance after confirming Mounjaro use. The Tesla CEO's 'Ozempic Santa' post ignited speculation on GLP-1 drugs' role in his 30-pound weight loss. Understand the science behind 'Mounjaro face' and real transformations.
6 min read
Biggest Mistake GLP-1 Users Make, Doctor Says
More Americans are turning to GLP-1 drugs like Wegovy for weight loss, but experts warn of a critical error. The biggest mistake, says obesity specialist Dr. Katherine Saunders, is treating the prescription as the full treatment. Pairing meds with healthy habits amplifies benefits and sustains results.
5 min read
Telangana DCA Warns Against Unsupervised Semaglutide Use Amid Weight Loss Demand
The Telangana Drugs Control Administration (DCA) has issued a strong warning against unsupervised use of semaglutide, a popular GLP-1 drug for weight loss and Type-2 diabetes management. With generics now available from Sun Pharma, Dr. Reddy's, Zydus, and Glenmark following patent expiry, demand is surging—but so are risks like acute pancreatitis and kidney injury. Always consult a doctor for proper assessment and prescription.
5 min read
Should Employers Cover GLP-1 Drugs? 4 Key Facts to Consider
The launch of the first oral GLP-1 weight-loss drug, Wegovy pill, is sparking renewed interest among employees wary of injections. But as demand surges, employers face tough choices on coverage amid high costs and side effects. This guide outlines 4 key facts from industry experts to inform your benefits strategy.
6 min read
GLP-1 Drugs & Hair Loss: New Study Reveals Potential Risk
Emerging research is spotlighting a potential link between popular GLP-1 medications like Ozempic and Wegovy and hair loss conditions such as telogen effluvium and androgenetic alopecia. A study of nearly 550,000 patients found a significant association after 12 months of use, even after adjusting for key factors. While benefits for diabetes and weight loss remain strong, awareness and monitoring are crucial.
6 min read
HIMS Shares Sink After FDA Vows Swift Action on Copycat GLP-1 Drugs
Hims & Hers Health's bold launch of a $49-per-month copycat GLP-1 pill to rival Wegovy's $149 price tag backfired spectacularly. FDA Commissioner Marty Makary vowed 'swift action' against such unapproved drugs, sending HIMS shares down 7.5% in premarket trading. This regulatory showdown highlights growing tensions in the GLP-1 market dominated by Novo Nordisk and Eli Lilly.
4 min read
Ozempic's Weight Reduction Enhances Airline Fuel Savings
Wall Street experts highlight unexpected benefits for airlines from GLP-1 medications like Ozempic, including significant fuel cost reductions due to lighter travelers. Analysts predict that widespread adoption could lead to billions in savings by reducing aircraft weight. This trend intersects pharmaceutical advancements with aviation economics.
4 min read
Health Minister Advances Wegovy's PBS Inclusion
The Australian government is set to partner with manufacturers to make Wegovy available on the Pharmaceutical Benefits Scheme for obesity management. This follows expert recommendations from the PBAC, addressing high private costs and equity in healthcare access.
2 min read
'Dancing With the Stars' Veteran Stephani Sosa Tackles Ozempic Buzz
Former 'Dancing With the Stars' troupe member Stephani Sosa openly discusses her use of Ozempic during the show and her ongoing health journey. She also shares details about liposuction and maintaining a fit lifestyle post-procedure. As she moves away from the series, Sosa focuses on new acting opportunities and personal growth.
2 min read
Returning to Baseline in 2 Years: Individuals Regain Weight More Quickly After Halting Obesity Medications Than Following a Diet
A University of Oxford study indicates that weight loss from medications like GLP-1 drugs often rebounds quickly upon cessation, faster than after dieting and exercise. Behavioral programs lead to slower regain, emphasizing sustainable lifestyle changes. Obesity impacts billions globally, raising risks for heart disease and diabetes.
2 min read
6 Facts to Understand About the New GLP-1 Weight Loss Pill
The introduction of a GLP-1 pill for weight loss marks a significant advancement in obesity treatment, offering an oral alternative to injections like Wegovy. Experts highlight its potential for broader access, though it shares similar expenses, adverse effects, and the necessity for a healthy lifestyle. Key details cover efficacy, timelines for results, pricing, side effects, dosing requirements, and upcoming options.
4 min read
Key Insights on Weight Loss Medications for 2026
Weight loss medications such as Wegovy and Zepbound are set to become more accessible and affordable, moving beyond high costs and weekly shots. New pill forms offer alternatives for those avoiding injections, with significant developments in GLP-1 treatments expected. Advances in pricing and access programs aim to broaden availability for patients.
6 min read
Is Ozempic Reshaping the Workplace?
This article explores the growing prevalence of weight-loss injections such as Ozempic in everyday life. It highlights rising adoption rates in the UK and US, potentially transforming workplace dynamics. Key statistics from research providers underscore the trend.
1 min read
Pills, TikTok, and Weight-Loss Apps: The Consumer-Focused Evolution of GLP-1 Drugs
The future of GLP-1 drugs for weight loss involves daily pills, smartphone apps for dose management, and easy access through telehealth, mirroring consumer goods like streaming services. As Novo Nordisk and Eli Lilly prepare pill versions, the obesity market could expand to $150 billion by the next decade. This shift emphasizes convenience, affordability, and lifestyle integration, but raises concerns about medical oversight and safety.
6 min read
Can Ozempic Trigger Muscle Loss? Expert Opinions
Weight-loss medications like Ozempic have gained immense popularity, but questions about potential muscle loss persist. Experts explain the mechanisms behind fat and muscle changes during treatment, emphasizing the importance of diet and exercise to maintain strength. Key strategies include resistance training and adequate protein to mitigate risks.
5 min read
GLP-1s & Hollywood: Decoding Clooney's Weight Loss Transformation
George Clooney's recent appearance sparked concerns about his health, with many attributing his weight loss to GLP-1 drugs like Ozempic. This raises important questions about the use of these medications and their impact on overall wellness and longevity.
3 min read